Clinical trial
An Early Feasibility Study to Assess Safety and Efficacy of the ChampioNIR® SFA Stent in the Treatment of Patients With Femoro-Popliteal Disease
NCT03775226 is registered in ClinicalTrials.gov with Medinol Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Early Feasibility Study to Assess Safety and Efficacy of the ChampioNIR® SFA Stent in the Treatment of Patients With Femoro-Popliteal Disease
- Lead sponsor
- Medinol Ltd.
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- October 27, 2019
- Completion date
- January 30, 2023
- Enrollment
- 22 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.